| Description |
1 online resource (xii, 287 pages) : illustrations (some color) |
| Series |
Methods in molecular biology ; v. 1687 |
|
Methods in molecular biology (Clifton, N.J.) ; v. 1687. 1064-3745
|
| Contents |
Overview of recent therapeutics advances for duchenne muscular dystrophy / Jean K. Mah -- Clinical manifestations and overall management strategies for duchenne muscular dystrophy / Takeshi Tsuda -- Cardiac involvement in duchenne muscular dystrophy and related dystrophinopathies / Sophie I. Mavrogeni, George Markousis-Mavrogenis, Antigoni Papavasiliou, George Papadopoulos, and Genovefa Kolovou -- Characterization of the inflammatory response in dystrophic muscle using flow cytometry / Jenna M. Kastenschmidt, Ileen Avetyan, and S. Armando Villalta -- Imaging analysis of the neuromuscular junction in dystrophic muscle / Stephen J.P. Pratt, Shama R. Iyer, Sameer B. Shah, and Richard M. Lovering -- System biology approach : gene network analysis for muscular dystrophy / Federica Censi, Giovanni Calcagnini, Eugenio Mattei, and Alessandro Giuliani -- Proteomic profiling of the dystrophin-deficient brain / Sandra Murphy and Kay Ohlendieck -- Probing the pathogenesis of duchenne muscular dystrophy using mouse models / Alexander Morrison-Nozik and Saptarsi M. Haldar -- Exon skipping therapy using phosphorodiamidate morpholino oligomers in the mdx52 mouse model of duchenne muscular dystrophy / Shouta Miyatake, Yoshitaka Mizobe, Hotake Takizawa, Yuko Hara, Toshifumi Yokota, Shinichi Takeda, and Yoshitsugu Aoki -- Designing effective antisense oligonucleotides for exon skipping / Takenori Shimo, Rika Maruyama, and Toshifumi Yokota -- Identification of splicing factors involved in DMD exon skipping events using an in vitro RNA binding assay / Julie Miro, Cyril F. Bourgeois, Mireille Claustres, Michel Koenig, and Sylvie Tuffery-Giraud -- Use of antisense oligonucleotides for the treatment of duchenne muscular dystrophy / Karima Relizani and Aurelie Goyenvalle -- PMO delivery system using bubble liposomes and ultrasound exposure for duchenne muscular dystrophy treatment / Yoichi Negishi, Yuko Ishii, Kei Nirasawa, Eri Sasaki, Yoko Endo-Takahashi, Ryo Suzuki, and Kazuo Maruyama -- Proton nuclear magnetic resonance (1H NMR) spectroscopy-based analysis of lipid components in serum/plasma of patients with duchenne muscular dystrophy (DMD) / Niraj Kumar Srivastava -- Test of antifibrotic drugs in a cellular model of fibrosis based on muscle-derived fibroblasts from duchenne muscular dystrophy patients / Simona Zanotti and Marina Mora -- Flow cytometry-defined CD49d expression in circulating T-lymphocytes is a biomarker for disease progression in duchenne muscular dystrophy / Wilson Savino, Fernanda Pinto-Mariz, and Vincent Mouly -- Advanced methods to study the cross talk between fibro-adipogenic progenitors and muscle stem cells / Luca Tucciarone, Usue Etxaniz, Martina Sandona, Silvia Consalvi, Pier Lorenzo Puri, and Valentina Saccone -- AAV6 vector production and purification for muscle gene therapy / Christine L. Halbert, James M. Allen, and Jeffrey S. Chamberlain -- From gRNA identification to the restoration of dystrophin expression : a dystrophin gene correction strategy for duchenne muscular dystrophy mutations using the CRISPR-induced deletion method / Benjamin Duchene, Jean-Paul Iyombe-Engembe, Joel Rousseau, Jacques P. Tremblay, and Dominique L. Ouellet |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Online resource; title from PDF title page (SpringerProtocol, viewed October 25, 2017) |
| Subject |
Duchenne muscular dystrophy -- Laboratory manuals
|
|
Muscular Dystrophy, Duchenne
|
|
Duchenne muscular dystrophy
|
| Genre/Form |
Laboratory manuals
|
|
Laboratory manuals.
|
|
Manuels de laboratoire.
|
| Form |
Electronic book
|
| Author |
Bernardini, Camilla, editor.
|
| ISBN |
9781493973743 |
|
1493973746 |
|
9781493973736 |
|
1493973738 |
|
